Skip to content
Reflections of yellow marbles on metal holders
Reflections of yellow marbles on metal holders

Life Sciences

Our global Life Sciences practice comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, veterinary, medtech, diagnostics and healthcare sectors.

The practice operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, commercial transactions (including licensing and collaborations), IP (both contentious and non-contentious), capital markets and finance, regulatory and dispute resolution. Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are well positioned to advise on cross-border work.

We have won a reputation for providing far-sighted advice to some of the world’s leading life science companies.

News and insights

A scientist at work in a laboratory

News: 29 September 2023

Allen & Overy advises on financing for Cinven’s takeover offer for Synlab

Allen & Overy (A&O) has advised 15 bank underwriters (Barclays Bank, BNP Paribas, Citibank, Crédit Agricole Corporate and Investment Bank, Deutsche Bank, Mizuho Bank, Natixis, Banco Santander, Goldman…

Read more
A picture of earth from space

News: 21 July 2023

A&O’s patent practices and lawyers secure top rankings in leading intellectual property platform

Intellectual Asset Management (IAM) Patent, the world’s leading patent business media platform, has released its annual rankings guide, listing 16 practices and 32 Allen & Overy lawyers. The platform…

Read more

Publications: 20 March 2023

Abuse of dominance enforcement paves path for digital reform

2022 saw a significant decrease in fines across the world for abuse of dominance cases. Authorities continued to focus on ‘Big Tech’, but were more willing to accept commitments from firms in place of…

Read more
test tubes and dropper

Blog Post: 08 March 2023

Podcast: Surviving the "valley of death" - How early-stage life sciences companies can overcome funding gaps and IP hurdles

Tine Carmeliet, Juno Hautekiet and Geert Glas discuss how early-stage life sciences companies can survive the so-called “valley of death”. This is the funding gap between making a promising scientific…

Read more


Related links

Life Sciences Talk

We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector.

Read more

CRISPR microsite

The characterisation and optimisation of the CRISPR (also known as CRISPR-Cas) system for gene editing and other applications, is undoubtedly one of the most powerful and ground breaking advances in the history of biotechnology.

Go to microsite

Tech Talk

We share our insights on the legal issues shaping the future of technology.

Read more

UPC microsite

Ready for take-off

Go to microsite

Related content

Global trends in merger control enforcement

Record levels in the first half of 2018 and considerable contraction in the second.